Openwater, a Newark, CA-based provider of a healthcare platform, raised $100M in total funding.
Backers included Plum Alley Ventures, Khosla Ventures, BOLD Capital Partners, Esther Dyson, Peter Gabriel, among others.
The company intends to use the funds to expand operations and its business reach.
Founded by CEO Mary Lou Jepsen, Openwater develops medical technology integrating infrared imaging, ultrasound, and electromagnetic fields to diagnose and treat diseases at the cellular level to enable visualization, monitoring, and treatment of biological issues. The technology can selectively destroy cancer cells while leaving healthy cells unaffected, similar to how an opera singer’s voice can shatter a specific wine glass without disturbing others.
The company collaborates with institutions to validate its technology and drive healthcare innovation. Using open-source principles and consumer electronics manufacturing, Openwater seeks to reduce medical device development time and costs. Collaborations with institutions including UCLA, the University of Arizona, the University of Pennsylvania, and Brown University have validated the technology’s potential across multiple medical fields.
FinSMEs
23/08/2024